Quest Diagnostics (DGX) Revenue & Quarterly History
Explore Quest Diagnostics Incorporated (DGX) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue increased in the current quarter. The growth reflects a continuation of the positive trend.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.9B
Revenue reported for this quarter.
Quarter-over-quarter
+3.2%
Change from the immediately preceding quarter.
Year-over-year
+9.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$11.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $2.5B | -3.8% |
| Sep 30, 2022 | $2.5B | -10.4% |
| Dec 31, 2022 | $2.3B | -15.0% |
| Mar 31, 2023 | $2.3B | -10.7% |
| Jun 30, 2023 | $2.3B | -4.7% |
| Sep 30, 2023 | $2.3B | -7.7% |
| Dec 31, 2023 | $2.3B | -1.9% |
| Mar 31, 2024 | $2.4B | +1.5% |
| Jun 30, 2024 | $2.4B | +2.5% |
| Sep 30, 2024 | $2.5B | +8.4% |
| Dec 31, 2024 | $2.6B | +14.6% |
| Mar 31, 2025 | $2.7B | +12.1% |
| Jun 30, 2025 | $2.8B | +15.2% |
| Sep 30, 2025 | $2.8B | +13.2% |
| Dec 31, 2025 | $2.8B | +7.1% |
| Mar 31, 2026 | $2.9B | +9.2% |
Revenue performance
Revenue rose compared to both the immediately preceding quarter and the same quarter last year.
Quarterly comparison
The sequential increase was modest, while the year-over-year gain was larger.
What to watch
Monitor the company's ability to sustain revenue growth in future quarters.